The results herein demonstrate that clodronate liposome-mediated KC depletion, regardless of VATM content in both DIO and ob/ob mice, abrogated hepatic steatosis by reducing hepatic denovo lipogenic gene expression. This evidence concerns the gene CALCA and fatty liver disease.